End-of-life care is challenging for even the most seasoned oncologist. Here are five suggestions that can help you better navigate this difficult but critical part of your work.
FDA Grants Accelerated Approval to Asciminib in Ph+ CML in Chronic Phase
Data from the ASC4FIRST trial support the accelerated approval of asciminib in this CML population.
Empowering Awareness to Address Rising Gynecological Cancer Incidence
Ginger J. Gardner, MD, FACOG, highlights disease prevention innovations and other ongoing efforts to empower education in the gynecologic cancer field.
FDA Expands Approval for Methotrexate in Pediatric ALL, pJIA Indications
The expanded approval of methotrexate may offer a convenient alternative to pediatric patients who have difficulty swallowing pills.
Leveraging Ex Vivo Gene Therapy Advancements in Hemoglobinopathies and Metabolic Diseases
A panel of expert pharmacists provides their perspectives on gene therapy agents such as exagamglogene autotemcel in the management of sickle cell disease.
IDE397 Shows Preliminary Efficacy in MTAP+ NSCLC and Urothelial Cancer
Phase 1 expansion data may support potential combination development for IDE397 in NSCLC and urothelial cancer harboring MTAP deletions.
The Evolving Landscape of Prostate Cancer Management
Maha Hussain, MD, FACP, FASCO, spoke about BRCA testing and ctDNA as diagnostic tools and PSMA-imaging and -targeted approaches in prostate cancer.